Paolo Baroldi
Galileo Research Executive Board Member
Clinical Development
Galileo Biotech
Italy
Biography
Paolo Baroldi, MD, PhD, has served as Senior Vice President of Clinical Development and Chief Medical Officer since 2009. Previously, Dr. Baroldi was Senior Vice President of Clinical Development and Chief Medical Officer at Supernus Pharmaceutical (Rockville, MD), Vice President of Corporate Drug Development and Chairman of the R&D Board at Chiesi Farmaceutici SpA, and the Global Head of Clinical Pharmacology at Novartis AG. Dr. Baroldi holds degrees in medicine and surgery and a PhD in clinical pharmacology from the University of Milan, and an Executive MBA from Harvard University. Currently, he is Senior Vice President and Chief Medical Officer at Vanda Pharmaceuticals.
Research Interest
Clinical Pharmacology
